Targeted Strategies for Today's Evolving Markets

MissionIR Blog

PURE Bioscience, Inc. (PURE) Starts Presentation at 2015 Marcum MicroCap Conference

PURE Bioscience is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. PURE’s patented technology platform is based on patented stabilized ionic silver; its initial products contain silver dihydrogen citrate (SCC), a broad-spectrum, non-toxic antimicrobial agent which offers 24-hour residual protection and formulates well with other compounds. SDC-based disinfecting and sanitizing products are registered by the EPA. For more information, visit the company’s website at www.purebio.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.